 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || UMC119-01 / Xuanjie
Enrollment open, Trial completion date, Trial primary completion date: Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (clinicaltrials.gov) - Dec 7, 2022
P1, N=9, Recruiting, Sponsor: Meridigen Biotech Co., Ltd.
Active, not recruiting --> Recruiting | Trial completion date: Jul 2025 --> Jul 2027 | Trial primary completion date: Dec 2022 --> Dec 2025
- | UMC119-01 / Xuanjie
Enrollment closed, Trial completion date, Trial primary completion date: Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (clinicaltrials.gov) - Apr 26, 2021
P1, N=9, Active, not recruiting, Sponsor: Meridigen Biotech Co., Ltd.
Active, not recruiting --> Recruiting | Trial completion date: Jul 2025 --> Jul 2027 | Trial primary completion date: Dec 2022 --> Dec 2025 Recruiting --> Active, not recruiting | Trial completion date: Oct 2022 --> Jul 2025 | Trial primary completion date: Oct 2020 --> Dec 2022
- | UMC119-01 / Xuanjie
Enrollment open: Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (clinicaltrials.gov) - Sep 23, 2019
P1, N=9, Recruiting, Sponsor: Meridigen Biotech Co., Ltd.
Recruiting --> Active, not recruiting | Trial completion date: Oct 2022 --> Jul 2025 | Trial primary completion date: Oct 2020 --> Dec 2022 Not yet recruiting --> Recruiting
- | UMC119-01 / Xuanjie
New P1 trial: Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (clinicaltrials.gov) - Aug 14, 2018
P1, N=9, Not yet recruiting, Sponsor: Meridigen Biotech Co., Ltd.
Not yet recruiting --> Recruiting .